The authors concluded that there was no evidence of therapeutic benefit favouring either antiplatelet or anticoagulant treatment in cervical dissection. However, given limitations in the evidence, definite conclusions could not be made. Despite the methodological limitations of the review, the authors' cautious conclusions appear to reflect the results.
Study selection
Prospective and retrospective studies that evaluated anticoagulation versus antiplatelet therapy, thrombolysis and stenting in cervical, vertebral or carotid dissection were eligible for inclusion. Only anticoagulation studies including acute treatment (within one month of symptom onset) were included. Studies that evaluated both intra-arterial and intravenous thrombolysis treatment were included. Studies with less than four patients, and studies that evaluated interracial or intracranial extension of extracranial dissection, were excluded from the review. Studies that did not clearly specify treatment groups were also excluded.
A number of outcomes of interest were presented for each type of therapy. The majority of included studies evaluated carotid dissection.
The authors did not state how the papers were selected for the review, or how many reviewers performed the selection.
Assessment of study quality
The authors did not state that they assessed validity.
Data extraction
Data on the number of outcomes in the intervention and comparator groups were extracted. Risk difference (RD) and 95% confidence intervals (CIs) were calculated.
Two reviewers independently extracted the data, with any disagreements resolved by consensus.
Methods of synthesis
Where possible, meta-analyses examining pooled risk differences and 95% confidence intervals were performed using a fixed-effect model. The authors did not state that they assessed heterogeneity, although results from χ2 tests and the I 2 statistic were presented in the forest plots.
